MedTrace Logo

Impact of Artificial Intelligence Genius® System-assisted Colonoscopy vs. Standard Colonoscopy (COLO-GENIUS)

NCT04440865 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2100

Last updated 2022-05-06

No results posted yet for this study

Summary

This controlled-randomized trial compares the artificial intelligence Genius® system assisted (Genius+) to standard (Genius-) colonoscopy.

The aim of this study was to evaluate the impact of Genius® system on ADR in routine colonoscopy. The secondary aims will be the impact of Genius® system on polyp detection rate (PDR), serrated polyp detection rate (SPDR), advanced neoplasia detection rate (ANDR), mean number of polyps (MNP), polyp type and localization, and operator type (according to basal ADR).

Conditions

  • Colonic Polyp
  • Colonoscopy
  • Artificial Intelligence
  • Colonic Adenoma
  • Colonic Neoplasms

Interventions

OTHER

Genius® System-assisted Colonoscopy

Genius® Intelligence System is used to assist Colonoscopy

OTHER

Standard Colonoscopy

Standard Colonoscopy without Genius® Intelligence System is performed

Sponsors & Collaborators

  • Clinique Paris-Bercy

    lead OTHER

Principal Investigators

  • David Karsenti, MD · Clinique Paris-Bercy

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-01
Primary Completion
2022-04-01
Completion
2022-04-20

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04440865 on ClinicalTrials.gov